No cure exists for Lou Gehrig’s disease, a fatal neuromuscular illness affecting tens of thousands of Americans. But scientists may have found how a key protein helps drive its degenerative progress.
Read/listen to my full story at KJZZ’s Arizona Science Desk:
UA, Barrow Researchers Explain ALS Key Protein Breakdown
Barrow Neurological Institute is working with IBM’s Jeopardy-winning supercomputer, Watson, to identify treatment targets for Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis, or ALS.
ALS is a poorly understood neuromuscular disease with only limited treatment options. Its capacity to strike anyone, at any time, seemingly without pattern, has puzzled researchers.
Read/listen to my full story at KJZZ’s Arizona Science Desk:
BM’s Watson Computer Helps Barrow Identify New ALS Genes